Literature DB >> 17922307

SHOX at a glance: from gene to protein.

Antonio Marchini1, Gudrun Rappold, Katja U Schneider.   

Abstract

The Short Stature Homeobox-containing Gene SHOX was identified as the genetic cause of the short stature phenotype in patients with Turner Syndrome and in certain patients with idiopathic short stature. Shortly after, SHOX mutations were also associated with the growth failure and skeletal deformities seen in patients with Léri - Weill dyschondrosteosis and Langer mesomelic dysplasia. Today it is estimated that SHOX mutations occur with an incidence of roughly 1:1,000 in newborns, making mutations of this gene one of the most common genetic defects leading to growth failure in humans. This review summarises the involvement of SHOX in several short stature syndromes and describes recent advances in our understanding of SHOX functions and regulation. We also discuss the current evidence in the literature that points to a role of this protein in growth and bone development. These studies have improved our knowledge of the SHOX gene and protein functions, and have given insight into the etiopathogenesis of short stature. However, the exact role of SHOX in bone development still remains elusive and poses the next major challenge for researchers in this field.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17922307     DOI: 10.1080/13813450701531201

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  11 in total

1.  Systematic molecular analyses of SHOX in Japanese patients with idiopathic short stature and Leri-Weill dyschondrosteosis.

Authors:  Hirohito Shima; Toshiaki Tanaka; Tsutomu Kamimaki; Sumito Dateki; Koji Muroya; Reiko Horikawa; Junko Kanno; Masanori Adachi; Yasuhiro Naiki; Hiroyuki Tanaka; Hiroyo Mabe; Hideaki Yagasaki; Shigeo Kure; Yoichi Matsubara; Toshihiro Tajima; Kenichi Kashimada; Tomohiro Ishii; Yumi Asakura; Ikuma Fujiwara; Shun Soneda; Keisuke Nagasaki; Takashi Hamajima; Susumu Kanzaki; Tomoko Jinno; Tsutomu Ogata; Maki Fukami
Journal:  J Hum Genet       Date:  2016-03-17       Impact factor: 3.172

2.  Transcription factor short stature homeobox 2 is required for proper development of tropomyosin-related kinase B-expressing mechanosensory neurons.

Authors:  Alexandra Scott; Hiroshi Hasegawa; Katsuyasu Sakurai; Avraham Yaron; John Cobb; Fan Wang
Journal:  J Neurosci       Date:  2011-05-04       Impact factor: 6.167

3.  A novel intronic mutation in SHOX causes short stature by disrupting a splice acceptor site: direct demonstration of aberrant splicing by expression of a minigene in HEK-293T cells.

Authors:  Jennifer Danzig; Michael A Levine
Journal:  J Pediatr Endocrinol Metab       Date:  2012       Impact factor: 1.634

4.  Short Stature in Isodicentric Y Chromosome and Three Copies of the SHOX Gene: Clinical Report and Review of Literature.

Authors:  Angelo Valetto; Veronica Bertini; Angela Michelucci; Benedetta Toschi; Eleonora Dati; Giampietro I Baroncelli; Silvano Bertelloni
Journal:  Mol Syndromol       Date:  2016-03-12

Review 5.  Epigenetic Dysfunction in Turner Syndrome Immune Cells.

Authors:  Bradly J Thrasher; Lee Kyung Hong; Jason K Whitmire; Maureen A Su
Journal:  Curr Allergy Asthma Rep       Date:  2016-05       Impact factor: 4.806

6.  Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.

Authors:  Katja U Schneider; Dimo Dietrich; Michael Fleischhacker; Gunda Leschber; Johannes Merk; Frank Schäper; Henk R Stapert; Erik R Vossenaar; Sabine Weickmann; Volker Liebenberg; Christoph Kneip; Anke Seegebarth; Fikret Erdogan; Gudrun Rappold; Bernd Schmidt
Journal:  BMC Cancer       Date:  2011-03-22       Impact factor: 4.430

7.  Rare inheritance of Leri-Weill Syndrome due to crossover of short stature Homeobox Gene (SHOX) Deletions between X and Y Chromosomes: a case report.

Authors:  Marisa Censani; Kwame Anyane-Yeboa; Ronald Wapner; Erica Spiegel; Edwin Guzman; Sharon E Oberfield
Journal:  Int J Pediatr Endocrinol       Date:  2013-06-28

8.  All Madelung deformities are not endocrine.

Authors:  Ajay Kumar; Gopal K Rai; Javed Akhtar; Rajeev Phillip; Manish Gutch; T V S Arya
Journal:  Indian J Endocrinol Metab       Date:  2013-10

Review 9.  A Track Record on SHOX: From Basic Research to Complex Models and Therapy.

Authors:  Antonio Marchini; Tsutomu Ogata; Gudrun A Rappold
Journal:  Endocr Rev       Date:  2016-06-29       Impact factor: 19.871

10.  Retinoic acid catabolizing enzyme CYP26C1 is a genetic modifier in SHOX deficiency.

Authors:  Antonino Montalbano; Lonny Juergensen; Ralph Roeth; Birgit Weiss; Maki Fukami; Susanne Fricke-Otto; Gerhard Binder; Tsutomu Ogata; Eva Decker; Gudrun Nuernberg; David Hassel; Gudrun A Rappold
Journal:  EMBO Mol Med       Date:  2016-12-01       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.